These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 4307623)

  • 1. [Purification of Cl. perfringens anatoxin by the method of electrophoretic convection].
    Samsonova VS; Nikitina VD; Kholchev NV; Volkova ZM
    Zh Mikrobiol Epidemiol Immunobiol; 1967 Jun; 44(6):93-7. PubMed ID: 4307623
    [No Abstract]   [Full Text] [Related]  

  • 2. [Purification of the toxoids of Cl. Perfringens and Cl. pedematiens using silicagel].
    Efimova NP; Tul'bovich EV
    Zh Mikrobiol Epidemiol Immunobiol; 1977; (1):82-6. PubMed ID: 190831
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A comparative study of the antigenic and immunogenic properties of the anatoxin of Cl. perfringens, concentrated and purified by various methods].
    Larina IA; Samsonova VS; Volkova ZM
    Zh Mikrobiol Epidemiol Immunobiol; 1968 Apr; 45(4):86-9. PubMed ID: 4309741
    [No Abstract]   [Full Text] [Related]  

  • 4. Purification of Clostridium toxoids.
    Buchowicz I; Hay M; Schiller B; Korbecki M; Sochańska R
    Acta Microbiol Pol; 1977; 26(3):285-94. PubMed ID: 70974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Immunogenic properties of Cl. perfringens anatoxins obtained from purified toxins].
    Dmitrieva LN; Shemanova GF; Akhundova KA; Vlasova EV; Il'nitskaia KA
    Zh Mikrobiol Epidemiol Immunobiol; 1975 Nov; (11):134-6. PubMed ID: 176848
    [No Abstract]   [Full Text] [Related]  

  • 6. [Homogeneous Cl. perfringens alpha-anatoxin: its physicochemical and immunogenic properties].
    Shemanova GF; Petrov RV; Dmitrieva LN; Panteleev EI; Drachev VA
    Zh Mikrobiol Epidemiol Immunobiol; 1978 May; (5):117-22. PubMed ID: 208330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Scientific achievements in the field of anatoxin production].
    Efimova NP; Nikolaeva AM; Kameneva MA; Semenova VD; Pushkareva EV; Luzina TA; Efimova MG; Griaznova DV
    Zh Mikrobiol Epidemiol Immunobiol; 1998; (2):28-32. PubMed ID: 9662793
    [No Abstract]   [Full Text] [Related]  

  • 8. [Purification and concentration of Cl. botulinum type F anatoxin].
    Blagoveshchenskiĭ VA; Reshetnikova LN; Bulatova TI; Perova EV
    Zh Mikrobiol Epidemiol Immunobiol; 1972 Sep; 49(9):22-5. PubMed ID: 4569262
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of Clostridium toxoids, especially of Clostridium perfringens toxoid, on mouse transplanted tumors.
    Sasaki T; Chihara G; Takasuka N; Suzuki S
    Gan; 1976 Apr; 67(2):275-7. PubMed ID: 184006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Toxins and anatoxins of Clostridium perfringens].
    Cherkas GP; Kalinichenko MF; Biriukova SV; Podgornaia LG
    Mikrobiol Zh; 1971; 33(2):173-5. PubMed ID: 4326475
    [No Abstract]   [Full Text] [Related]  

  • 11. Induction of potential protective immunity against enterotoxemia in calves by single or multiple recombinant Clostridium perfringens toxoids.
    Jiang Z; De Y; Chang J; Wang F; Yu L
    Microbiol Immunol; 2014 Nov; 58(11):621-7. PubMed ID: 25197030
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro tests for the measurement of clostridial toxins, toxoids and antisera. II. Titration of Clostridium perfringens toxins and antitoxins in cell culture.
    Knight PA; Queminet J; Blanchard JH; Tilleray JH
    Biologicals; 1990 Oct; 18(4):263-70. PubMed ID: 2285500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Study of delayed-type hypersensitivity to the administration of Cl. perfringens anatoxin].
    Kalinichenko NF; Podgornaia LG; Biriukova SV
    Zh Mikrobiol Epidemiol Immunobiol; 1972 Sep; 49(9):25-8. PubMed ID: 4347172
    [No Abstract]   [Full Text] [Related]  

  • 14. [Physico-chemical and immunobiological properties of the ribosomal preparations of Clostridium perfringens, type A].
    Efimova MG
    Zh Mikrobiol Epidemiol Immunobiol; 1998; (2):46-9. PubMed ID: 9662798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunogenicity of highly purified -toxoid of Clostridium perfringens.
    Sato H; Kameyama S; Murata R
    Jpn J Med Sci Biol; 1972 Feb; 25(1):53-6. PubMed ID: 4338981
    [No Abstract]   [Full Text] [Related]  

  • 16. [PURIFICATION AND CONCENTRATION OF CL. PERFRINGENS TOXOID WITH THE USE OF NO ANION EXCHANGE RESIN].
    SAMSONOVA VS; DAVANKOV AB; LAUFER VM
    Zh Mikrobiol Epidemiol Immunobiol; 1964 Feb; 41():98-102. PubMed ID: 14178360
    [No Abstract]   [Full Text] [Related]  

  • 17. [Characteristics of the immunologic response of animals to Clostridium perfringens anatoxin].
    Petrov RV; Shemanova GF; Panteleev EI; Dmitrieva LN; Vlasova EV
    Zh Mikrobiol Epidemiol Immunobiol; 1977 May; (5):71-4. PubMed ID: 197752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Prevention of anaerobic infections of ruminants in Madagascar by intradermal administration of ultrafiltered toxoids of locally specific clostridia].
    Seifert HS; Böhnel H; Ranaivoson A
    Dtsch Tierarztl Wochenschr; 1983 Jul; 90(7):274-9. PubMed ID: 6311508
    [No Abstract]   [Full Text] [Related]  

  • 19. Enzymatic activation of Clostridium perfringens epsilon prototoxin and some biological properties of activated toxin.
    Worthington RW; Mülders MS; Van Rensburg JJ
    Onderstepoort J Vet Res; 1973 Dec; 40(4):151-4. PubMed ID: 4369993
    [No Abstract]   [Full Text] [Related]  

  • 20. [Sensitizing properties of purified concentrated Cl. perfringens toxoids].
    Kalinichenko NF; Starobinets ZG; Podgornaia LG; Biriukova SV
    Zh Mikrobiol Epidemiol Immunobiol; 1971 Oct; 48(10):113-5. PubMed ID: 4330843
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.